subject area of
- 5-Aminosalicylates Prevent Relapse of Crohn's Disease After Surgically Induced Remission: Systematic Review and Meta-Analysis Academic Article
- A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group Conference Paper
- Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease Academic Article
- Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials Academic Article
- Effects of mesalamine (5-aminosalicylic acid) on bacterial gene expression Academic Article
- Efficacy of 5-Aminosalicylates in Crohn's Disease: Systematic Review and Meta-Analysis Academic Article
- Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis Academic Article
- Efficacy of Oral vs. Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Meta-Analysis Academic Article
- Efficacy of Topical 5-Aminosalicylates in Preventing Relapse of Quiescent Ulcerative Colitis: A Meta-analysis Academic Article
- Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission Conference Paper
- Interstitial Nephritis in Patients with Inflammatory Bowel Disease Treated with Mesalamine Academic Article
- Ketotifen Treatment of Active Colitis in Patients with 5-Aminosalicylate Intolerance Academic Article
- Letter: mesalazine—a safe drug with rare serious adverse events? Authors’ reply Academic Article
- Mesalamine (5-ASA) for the prevention of recurrent diverticulitis Academic Article
- Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome Academic Article
- Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis Academic Article
- Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis Academic Article
- New Applications for Traditional Drugs in Inflammatory Bowel Disease Academic Article
- Once-Daily Dosing vs. Conventional Dosing Schedule of Mesalamine and Relapse of Quiescent Ulcerative Colitis: Systematic Review and Meta-Analysis Academic Article
- Oral budesonide for induction of remission in ulcerative colitis Academic Article
- Oral budesonide for induction of remission in ulcerative colitis Academic Article
- Putting Rectal 5-Aminosalicylic Acid in Its Place: The Role in Distal Ulcerative Colitis Academic Article
- Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis Academic Article
- Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis Academic Article
- Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Academic Article
- Resource utilization during pediatric to adult transfer of care in IBD Academic Article
- Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis Academic Article
- Systematic review: safety of mesalazine in ulcerative colitis Academic Article
- Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial Academic Article